0001127602-23-015939.txt : 20230517
0001127602-23-015939.hdr.sgml : 20230517
20230517163132
ACCESSION NUMBER: 0001127602-23-015939
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20230515
FILED AS OF DATE: 20230517
DATE AS OF CHANGE: 20230517
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Lingamneni Anila
CENTRAL INDEX KEY: 0001808414
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-14041
FILM NUMBER: 23932213
MAIL ADDRESS:
STREET 1: HAEMONETICS CORPORATION
STREET 2: 125 SUMMER STREET
CITY: BOSTON
STATE: MA
ZIP: 02110
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: HAEMONETICS CORP
CENTRAL INDEX KEY: 0000313143
STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
IRS NUMBER: 042882273
STATE OF INCORPORATION: MA
FISCAL YEAR END: 0401
BUSINESS ADDRESS:
STREET 1: 125 SUMMER STREET
CITY: BOSTON
STATE: MA
ZIP: 02110
BUSINESS PHONE: 7818487100
MAIL ADDRESS:
STREET 1: 125 SUMMER STREET
CITY: BOSTON
STATE: MA
ZIP: 02110
4
1
form4.xml
PRIMARY DOCUMENT
X0407
4
2023-05-15
0000313143
HAEMONETICS CORP
HAE
0001808414
Lingamneni Anila
125 SUMMER STREET
BOSTON
MA
02110
1
EVP, Chief Technology Officer
0
Common Stock
2023-05-15
4
A
0
3364
A
20807
D
Common Stock
2023-05-16
4
F
0
318
89.21
D
20489
D
Non-qualified Stock Option (Right to Buy)
89.16
2023-05-15
4
A
0
7602
0
A
2030-05-15
Common Stock
7602
7602
D
The securities awarded are in the form of restricted stock units ("RSUs") issued pursuant to the Haemonetics Corporation 2019 Long-Term Incentive Compensation Plan. The RSUs vest in three equal annual installments beginning on the first anniversary of the date of grant.
Each RSU represents a contingent right to receive one (1) share of the Issuer's common stock when vested.
This number includes unvested RSUs previously reported as well as 297 shares acquired by the reporting person under the Issuer's 2007 Employee Stock Purchase Plan (as amended) on April 28, 2023.
Represents shares withheld for tax obligations in connection with the vesting of certain RSUs previously reported in Table I.
Option vests in annual increments of 25% beginning on the first anniversary of the date of grant.
/s/ Thomas V. Powers, attorney-in-fact for Ms. Lingamneni
2023-05-17